Health Catalyst Price Target Raised to $13.00/Share From $10.00 by JP Morgan
J.P. Morgan Maintains Health Catalyst(HCAT.US) With Buy Rating, Raises Target Price to $13
J.P. Morgan analyst Anne Samuel maintains $Health Catalyst(HCAT.US)$ with a buy rating, and adjusts the target price from $10 to $13.According to TipRanks data, the analyst has a success rate of 50.5%
CCORF Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $11
CCORF analyst Richard Close maintains $Health Catalyst(HCAT.US)$ with a buy rating, and maintains the target price at $11.According to TipRanks data, the analyst has a success rate of 53.0% and a
Buy Rating Affirmed on Health Catalyst Amid Positive Growth and Strategic Initiatives
Health Catalyst to Participate in Upcoming Investor Conferences
Express News | Wishin Expands Relationship With Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite
WISHIN Expands Relationship With Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe Suite
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
Health Catalyst Is Maintained at Overweight by Piper Sandler
Piper Sandler Maintains Overweight on Health Catalyst, Lowers Price Target to $11
Piper Sandler Maintains Health Catalyst(HCAT.US) With Buy Rating, Cuts Target Price to $11
Piper Sandler analyst Jessica Tassan maintains $Health Catalyst(HCAT.US)$ with a buy rating, and adjusts the target price from $14 to $11.According to TipRanks data, the analyst has a success rate
Express News | Health Catalyst Inc : Piper Sandler Cuts Target Price to $11 From $14
One Health Catalyst Insider Raised Their Stake In The Previous Year
Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target
Barclays Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $14
Barclays analyst Stephanie Davis maintains $Health Catalyst(HCAT.US)$ with a buy rating, and maintains the target price at $14.According to TipRanks data, the analyst has a success rate of 42.7% and
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT)
Health Catalyst (HCAT) Receives a Buy From Barclays
Health Catalyst Shares Are Trading Lower After Rising on Thursday Following Strong Q2 Earnings.
The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts
Health Catalyst Price Target Maintained With a $16.00/Share by Cantor Fitzgerald